Viewing Study NCT03399734

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:34 AM
Ignite Modification Date: 2026-01-07 @ 3:26 PM
Study NCT ID: NCT03399734
Status: COMPLETED
Last Update Posted: 2018-10-29
First Post: 2018-01-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Bioequivalence Study Between a 4-mg Dose of Fine Granules of Perampanel and a 4-mg Tablet of Perampanel in Healthy Japanese Subjects
Sponsor: Eisai Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy Participants View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Perampanel View
None Bioequivalence View
None fine granules View
None E2007 View
None Japanese View